Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.
J.P. Morgan analyst Seiji Wakao maintained a Hold rating on PHC Holdings Corp. (2GY – Research Report) yesterday and set a price target of ...
Northern TK Venture filed a claim against Daiichi Sankyo saying the latter prevented NTK from proceeding with its open offer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback